Ovary stimulation without IVF in polycystic ovary syndrome;La stimulation hors FIV dans le syndrome des ovaires polymicrokystiques

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 32, Issue 3 II, 2003, Pages

  Dewailly, D ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE INHIBITOR; CLOMIFENE; FOLLITROPIN; GONADORELIN; LUTEINIZING HORMONE;

ANOVULATION; CLINICAL PROTOCOL; CONFERENCE PAPER; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; OVARY FOLLICLE DEVELOPMENT; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE;

EID: 17344380262     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (19)

1. Dewallly D, Cortet-Rudelli C, Decanter C. The Polycystic Ovary Syndrome. Reproductive Aspects. In the Oxford Textbook of Endocrinology, JAH Wass & SM Shalet, Eds. Oxford University Press, 2003, à paraître.
2. Van der meer M, Hompes PGA, De Boer JAM, Schats R, Schoemaker J. Cohort size rather than follicle-stimulating hormone threshold level determines ovarian sensitivity in polycystic ovary syndrome. J Clin Endocrinol Metab 1998; 83: 423-6.
3. Messinis IE, Milingos SD. Current and future status of ovulation induction in polycystic ovary syndrome. Human Reproduction Update 1997; 3: 235-53.
4. Imani B, Eijkemans MJ, te Velde ER, Habbema JD, Fauser BC. Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab 1998; 83: 2361-5.
5. Imani B, Eijkemans MJ, Te Velde ER, Habbeba JD, Fauser BC. A normogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligomenorrheic infertility. Fertil Steril 2002; 77: 91-7.
6. Bayram N, van Wely M, van der Veen F. Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome. Cochrane Database Syst Rev 2001; 2: CD002121.
7. White DM, Polson DW, Kiddy D, Sagle P, Watson H, Gilling-Smith C, et al. Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women. J Clin Endocrinol Metab 1996; 81: 3821-4.
8. Fauser BCJM. Step down follicle stimulating hormone regimens in PCOS. In: Filicori M, Flamigni C, eds. Ovulation Induction: Basic Science and Clinical Advances. Amsterdam: Excerpta Medica 1994; 153-62.
9. Imani B, Eijkemans MJ, Faessen GH, Bouchard P, Giudice LC, Fauser BC. Prediction of the individual follicle-stimulating hormone threshold for gonadotropin induction of ovulation in normogonadotropic anovulatory infertility: an approach to increase safety and efficiency. Fertil Steril 2002; 77: 83-90.
10. Donesky BW, Adashi EY. Surgically induced ovulation in the polycystic ovary syndrome: wedge resection revisited in the age of laparoscopy. Fertil Steril 1995, 63: 439-63.
11. Farquhar C, Vandekerckhove P, Lilford R. Laparoscopic "drilling" by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome. Cochrane Database Syst Rev 2001; 4: CD001122.
12. Fernandez H, Alby JD, Gervaise A, de Tayrac R, Frydman R. Operative transvaginal hydrolaparoscopy for treatment of polycystic ovary syndrome: a new minimally invasive surgery. Fertil Steril 2001; 75: 607-11.
13. Buckett WM, Tan SL. Use of luteinizing hormone releasing hormone agonists in polycystic ovary syndrome. Baillieres Clin Obstet Gynaecol 1998; 12: 593-606.
14. Hughes E, Collins J, Vandekerckhove P. Gonadotrophin-releasing hormone analogue as an adjunct to gonadotropin therapy for clomiphene-resistant polycystic ovarian syndrome. Cochrane Database Syst Rev 2000; 2: CD000097.
15. Bayram N, van Wely M, Vandekerckhove P, Lilford R, van Der Veen F. Pulsatile luteinising hormone releasing hormone for ovulation induction in subfertility associated with polycystic ovary syndrome. Cochrane Database Syst Rev 2000; 2: CD000412.
16. Gill S, Taylor AE, Martin KA, Welt CK, Adams JM, Hall JE. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome. J Clin Endocrinol Metab 2001; 86: 2428-36.
17. Mitwally MF, Casper RF. Aromatase inhibition for ovarian stimulation: future avenues for infertility management. Curr Opin Obstet Gynecol 2002; 14: 255-63.
18. Mitwally MF, Casper RF. Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders (1). Fertil Steril 2002; 77: 776-80.
19. Mitwally MF, Casper RF. Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril 2001; 75: 305-9.